If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?It has been a good day for companies involved in peptide drug design and development. News broke this morning that Metsera and its portfolio of glucagon like peptide 1 receptor agonist ("GLP-1 RA") drugs is set to ...